
OFIX
Orthofix Medical Inc.
$14.86
+$0.15(+1.02%)
30
Overall
--
Value
30
Tech
--
Quality
Market Cap
$586.09M
Volume
239.92K
52W Range
$10.24 - $20.73
Target Price
$22.55
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $396.5M | $409.8M | $433.8M | $453.0M | $460.0M | $406.6M | $464.5M | $460.7M | $746.6M | $799.5M | ||
Total Revenue | $396.5M | $409.8M | $433.8M | $453.0M | $460.0M | $406.6M | $464.5M | $460.7M | $746.6M | $799.5M | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | $-86.5M | $-87.9M | $-93.0M | $-96.6M | $100.6M | $101.9M | $114.9M | $123.5M | $260.4M | $253.6M | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $310.0M | $321.9M | $340.8M | $356.4M | $359.3M | $304.7M | $349.6M | $337.2M | $486.3M | $545.9M | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $300.7M | $286.5M | $300.0M | $326.3M | $309.7M | $311.9M | $322.7M | $357.8M | $610.6M | $606.2M | ||
Research & Development | $26.4M | $28.8M | $29.7M | $33.2M | $34.6M | $39.1M | $49.6M | $49.1M | $80.2M | $73.6M | ||
Research Expense | $26.4M | $28.8M | $29.7M | $33.2M | $34.6M | $39.1M | $49.6M | $49.1M | $80.2M | $73.6M | ||
Selling, General & Administrative | $265.2M | $255.7M | $270.3M | $288.8M | $309.3M | $272.4M | $290.7M | $308.8M | $530.4M | $532.5M | ||
Selling & Marketing Expenses | $178.1M | $181.3M | $198.4M | $205.5M | $223.7M | $204.4M | $221.3M | $228.8M | $385.7M | -- | ||
General & Administrative Expenses | $87.2M | $74.4M | $71.9M | $83.3M | $85.6M | $67.9M | $69.4M | $80.0M | $530.4M | $532.5M | ||
Promotion & Advertising | -- | -- | -- | $-600.0K | $800.0K | $900.0K | $500.0K | $500.0K | $500.0K | -- | ||
Salaries & Wages | $9.1M | $2.0M | $-12.6M | $4.3M | $-34.2M | $499.0K | $-17.6M | $-3.3M | $-5.8M | $-5.8M | ||
Depreciation & Amortization | $-20.9M | $-20.8M | $-20.1M | $-18.7M | $24.7M | $30.5M | $29.6M | $29.0M | $53.1M | $60.1M | ||
Depreciation & Amortization | $-20.9M | $-20.8M | $-20.1M | $-18.7M | $24.7M | $30.5M | $29.6M | $29.0M | $53.1M | $60.1M | ||
Amortization | $-4.4M | $-1.8M | $-1.8M | $-2.7M | $72.1M | $85.8M | $73.4M | $72.6M | $195.9M | $195.9M | ||
Other Operating Expenses | $-300.7M | $-300.9M | $-300.0M | $-326.3M | $-309.0K | $-568.0K | $-45.0K | $-46.0K | $-416.0K | $-40.0K | ||
OPERATING INCOME | ||||||||||||
Operating income | $9.3M | $35.4M | $40.8M | $30.1M | $-18.8M | $-6.3M | $-8.3M | $-13.3M | $-139.1M | $-84.6M | ||
EBITDA | $31.2M | $41.4M | $57.4M | $41.8M | $750.0K | $36.4M | $21.4M | $15.7M | $-43.4M | $-6.1M | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | -- | -- | -- | -- | $122.0K | $2.5M | $1.8M | $1.3M | $8.6M | $29.6M | ||
Net Non-Operating Interest Income/Expense | -- | -- | -- | -- | $-122.0K | $-2.5M | $-1.8M | $-1.3M | $-8.6M | $-29.6M | ||
Gain on Sale of Securities | -- | $2.7M | $5.6M | -- | -- | -- | -- | $187.0K | $1.8M | $5.1M | ||
Other Income/Expense | $259.0K | $79.0K | $-1.6M | $6.4M | $8.1M | $-8.4M | $3.3M | $4.3M | $938.0K | $9.6M | ||
Other Special Charges | $-259.0K | $-2.8M | $-4.0M | $-6.4M | $-8.1M | $8.4M | $-3.3M | $-3.1M | $-938.0K | $-9.6M | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | -- | $-3.0M | -- | $-500.0K | -- | -- | -- | $-12.0M | $-36.6M | $-14.5M | ||
Special Income Charges | $1.3M | $-14.4M | $5.6M | $500.0K | -- | -- | $-11.8M | $11.2M | $22.1M | $-1.3M | ||
Impairment of Capital Assets | -- | -- | -- | -- | -- | -- | $11.8M | -- | -- | -- | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $8.5M | $19.0M | $35.6M | $22.1M | $-27.7M | $2.1M | $-11.7M | $-16.4M | $-140.0M | $-94.2M | ||
Pre-Tax Income | $8.5M | $19.0M | $36.4M | $22.9M | $-27.0M | $-368.0K | $-13.5M | $-17.7M | $-148.7M | $-123.9M | ||
INCOME TAX | ||||||||||||
Tax Provision | $10.8M | $15.5M | $29.1M | $9.1M | $1.4M | $-2.9M | $24.9M | $2.0M | $2.7M | $2.1M | ||
NET INCOME | ||||||||||||
Net Income | $-2.8M | $5.8M | $11.8M | $13.8M | $-28.5M | $2.5M | $-38.4M | $-19.7M | $-151.4M | $-126.0M | ||
Net Income (Continuing Operations) | $-2.8M | $5.8M | $11.8M | $13.8M | $-28.5M | $2.5M | $-38.4M | $-19.7M | $-151.4M | $-126.0M | ||
Net Income (Discontinued Operations) | $-2.8M | $5.8M | $11.8M | $13.8M | $-28.5M | $2.5M | $-38.4M | $-19.7M | $-151.4M | $-126.0M | ||
Net Income (Common Stockholders) | $-2.8M | $5.8M | $11.8M | $13.8M | $40.0M | $2.5M | $-38.4M | $-19.7M | $-151.4M | $-126.0M | ||
Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-114.5M | ||
TOTALS | ||||||||||||
Total Expenses | $214.2M | $198.6M | $206.9M | $229.7M | $410.3M | $413.8M | $437.6M | $481.4M | $871.0M | $859.8M | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $18.8M | $18.1M | $18.1M | $18.5M | $18.9M | $19.3M | $19.7M | $20.1M | $36.7M | $38.1M | ||
Average Shares Outstanding (Diluted) | $18.8M | $18.5M | $18.5M | $18.9M | $18.9M | $19.4M | $19.7M | $20.1M | $36.7M | $38.1M | ||
Shares Outstanding | $18.4M | $17.9M | $18.4M | $19.1M | $19.2M | $19.5M | $19.9M | $36.5M | $37.4M | $39.0M | ||
Basic EPS | $0.18 | $0.17 | $0.34 | $0.73 | $-1.51 | $0.13 | $-1.95 | $-0.98 | $-4.12 | $-3.3 | ||
Basic EPS (Continuing Operations) | $-0.12 | $0.19 | $0.40 | $0.73 | $-1.51 | $0.13 | $-1.95 | $-0.98 | $-4.12 | $-3.3 | ||
Diluted EPS | $0.18 | $0.17 | $0.34 | $0.72 | $-1.51 | $0.13 | $-1.95 | $-0.98 | $-4.12 | $-3.3 | ||
Diluted EPS (Continuing Operations) | $-0.12 | $0.19 | $0.39 | $0.72 | $-1.51 | $0.13 | $-1.95 | $-0.98 | $-4.12 | $-3.3 | ||
OTHER METRICS | ||||||||||||
Acquired In Process Rn D | -- | -- | $5.6M | -- | -- | -- | -- | -- | -- | -- | ||
Acquired In Process Rn D Income | -- | -- | $5.6M | -- | -- | -- | -- | -- | -- | -- | ||
Basic Discontinuous Operations | $-0.03 | $-0.02 | $-0.06 | -- | -- | -- | -- | -- | -- | -- | ||
Diluted Discontinuous Operations | $-0.03 | $-0.02 | $-0.05 | -- | -- | -- | -- | -- | -- | -- | ||
Gains Loss On Disposal Of Discontinued Operations | $-467.0K | $-441.0K | $-1.1M | -- | -- | -- | -- | -- | -- | -- | ||
Interest Expense Operating | -- | -- | $-800.0K | $-800.0K | $-800.0K | $-1.9M | $-1.5M | $-1.4M | $-5.8M | $-16.9M | ||
Net Income Discontinuous Operations | $-467.0K | $-441.0K | $-1.1M | -- | -- | -- | -- | -- | -- | -- | ||
Net Operating Interest Income Expense | $-489.0K | $763.0K | $-416.0K | $-828.0K | -- | -- | -- | -- | -- | -- | ||
Non Recurring Operation Expense | $-1.3M | $14.4M | -- | -- | -- | -- | -- | $803.0K | $14.5M | $15.8M | ||
Other Gand A | $87.2M | $74.4M | $71.9M | $83.3M | $85.6M | $67.9M | $69.4M | $80.0M | $530.4M | $532.5M | ||
Other Impairment Of Capital Assets | -- | -- | -- | $4.7M | -- | -- | -- | -- | $400.0K | -- | ||
Other Write Off | -- | -- | -- | -- | -- | $714.0K | $126.0K | $450.0K | $-137.0K | -- | ||
Rent And Landing Fees | $87.2M | $74.4M | $71.9M | $83.3M | -- | -- | -- | -- | -- | -- | ||
Selling Expense | $178.1M | $181.3M | $198.4M | $205.5M | -- | -- | -- | -- | -- | -- | ||
Write Down | -- | -- | $-5.6M | -- | -- | -- | -- | -- | -- | -- | ||
Restruct | -- | $-3.0M | -- | $-500.0K | -- | -- | -- | $-12.0M | $-36.6M | $-14.5M |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | OFIX | $14.86 | +1.0% | 239.92K |
3 | ||||
4 | ||||
5 | ||||
6 |